Novartis announces intention to separate Sandoz business to …
https://www.novartis.com/news/media-releases/novartis-announces-intention-separate-sandoz-business-create-standalone-company-way-100-spin
WebAug 25, 2022. Ad hoc announcement pursuant to Art. 53 LR. Sandoz strategic review concludes that a separation of Sandoz by way of a 100% spin-off is in the best interest of shareholders, creating the #1 European generics company and a global leader in biosimilars, and a more focused Novartis. Planned 100% spin-off would allow Novartis ...
DA: 87 PA: 48 MOZ Rank: 31